Abstracts

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30 Wed, Oct 01

Monday, September 29

5:00 PM - 6:00 PM PT

Radiation and Cancer Physics 4: Novel Treatment Techniques and Early Clinical  Experience
Speaker: Kovalchuk, Nataliya, PhD - Stanford University School of Medicine, Palo Alto, CA
5:00 PM - 6:00 PM PT

Radiation and Cancer Physics 4: Novel Treatment Techniques and Early Clinical  Experience
Speaker: Zhang, Yin, PhD - Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
5:05 PM - 5:10 PM PT

1024 - Phase I Study of Hypofractionated Whole Pelvis Radiation in Endometrial Cancer Using a Novel Patient-Reported Outcomes Continual Reassessment Method (PRO-CRM)
Speaker: Feldkamp, Sarah, MD - University of Cincinnati, Cincinnati, OH
5:05 PM - 5:10 PM PT

1030 - The Impact of HIV Status on Vaginal Stenosis among Cervical Cancer Patients Receiving Radiotherapy in Low- And Middle-Income Countries: A Single Center Prospective Study
Speaker: Seppo, Samuel Franck, MD - Henry Ford Health/Henry Ford Hospital, Detroit, MI
5:10 PM - 5:15 PM PT

1025 - Clinicopathologic and Molecular Heterogeneity of Aggressive Endometrial Carcinoma in the 2023 FIGO Staging System: A Dual-Cohort Retrospective and Prospective Analysis
Speaker: Ren, Kang, MD, PhD - Peking Union Medical College Hospital, Beijing, Beijing
5:10 PM - 5:15 PM PT

1031 - Hypofractionated Radiotherapy for Prostate Cancer: Preliminary Results from the HypoAfrica Study
Speaker: Kibudde, Solomon, MD, MMed - Uganda Cancer Institute, Kampala, Kampala
5:10 PM - 5:20 PM PT

259 - Standard of Care Systemic Treatment with or without Stereotactic Body Radiation Therapy (SBRT) in the Management of Patients with Newly Diagnosed Extra-cranial Oligometastatic Breast Cancer (OMBC): A Prospective Randomized Study (NCT06144346)
Speaker: Boutrus, Rimoun, MD, PhD - National Cancer Institute, Cairo University, Cairo, Al Qahirah
5:10 PM - 5:20 PM PT

264 - Ultra-Hypofractionated Stereotactic Ablative Body Radiotherapy (SABR) for Primary Renal Cell Carcinoma: Pooled Outcomes from the FASTRACK and FASTRACK II Clinical Trials
Speaker: Siva, Shankar, PhD, MBBS, FRANZCR - Peter MacCallum Cancer Centre, Parkville, VIC
5:10 PM - 5:20 PM PT

269 - Clinical and Genomic Predictors of Local Failure in NSCLC Patients Treated with Lung SBRT
Speaker: Patel, Roshal, MD - Memorial Sloan Kettering Cancer Center, New York, NY
5:10 PM - 5:20 PM PT

274 - First-in-Human Dual Modality Radiotherapy Treatment in a Single Plan Using Biology-Guided Radiotherapy: A Case Report
Speaker: Park, Henry, MD, MPH - Yale University, New Haven, CT
5:15 PM - 5:20 PM PT

1026 - Multi-Institutional Phase I Results from RT-PACE: Phase I/II Study of Adjuvant Whole Pelvic Hypofractionated Radiotherapy for Non-Metastatic Cervical and Endometrial Cancer
Speaker: Son, Christina, MD - University of Chicago Medicine, Chicago, IL
5:15 PM - 5:20 PM PT

1032 - The Impact of National Cancer Systems on Lung Cancer Mortality
Speaker: Dee, Edward, MD - Memorial Sloan Kettering Cancer Center, Middletown Township, NJ